|
|
CALENDAR OF EVENTS
NEXT EVENT:
|
Date:
Wednesday, July 22, 2009 |
Time:
7:00 am |
Open To:
Members & Non-Members |
| More Info > |
|
|
"The Future of Successful Investment in Biotech”
Wednesday, July 22, 7:00am - 9:00am
Hyatt Regency La Jolla at Aventine
Sponsored by Mayer Hoffman McCann, Pillsbury Winthrop Shaw Pittman, and Porter Novelli Life Sciences
The hope for biotech is well understood and, with a few fits and starts, has delivered - with exceptional and substantial contributions from San Diego. However, the situation for the US biotech industry is changing radically.
For business in general, the global economy has plummeted and capital formation and investments have gone into hibernation. For biotech specifically, promised health care reform will pressure the industry to be even more efficient with both time and money. Pockets of talented and determined resources are emerging around the world with efficiencies that are fundamentally changing drug development and healthcare strategy. Meanwhile, substantial changes to the US regulatory frameworks for drug approval and intellectual property protection are on the table.
So - what’s an investor to do?
To tackle our July meeting topic, the San Diego Venture Group is privileged to have a luminary in the biotech industry moderating the discussion of a panel featuring three experienced, successful and insightful investors – all of whom have been (and continue to be) active in the current environment.
Please join us on Wednesday, July 22 for a look into the future of successful investment in biotech!
Confirmed Panelists:
William Rastetter, Ph.D. (Moderator). Dr. Rastetter is the CEO and Executive Chairman of Receptos, Inc., a drug discovery/development company, as well as a Partner of Venrock Associates. Dr. Rastetter retired as the Executive Chairman of Biogen Idec Inc., a biopharmaceutical company, at the of 2005. Formerly known as IDEC Pharmaceuticals Corp., Dr. Rastetter led the company (including as CEO from 1986 through 2003) for 20 years. Before IDEC, Dr. Rastetter was with Genentech and, prior to that, was an associate professor at MIT. Dr. Rastetter holds a B.S. in Chemistry from MIT as well as an M.A. and a Ph.D. in Chemistry from Harvard.
Robert More, Partner, Frazier Healthcare. Previously, Mr. More was a Partner with Domain Associates, having joined that firm in 1996 as a Kauffman Fellow. Mr. More has served as COO of Small Molecule Therapeutics; with Pharmacia Biotech in sales; and in a research position at Somatogen. Mr. More serves as an advisory board member for Montagu Newhall Associates, Okapi Ventures, The Medical Industry Group of the National Venture Capital Association and The Sulpizio Family Cardiovascular Center. He is also a past founding board member of the Kauffman Fellows Program. Mr. More holds an MBA from Virginia and a BA from Middlebury.
Edward Torres, Co-Founder and Managing Director of Lilly Ventures, which is part of the New Ventures Division of Eli Lilly and Company. Previously, Mr. Torres had a diverse set of experiences throughout the domestic and international pharmaceutical businesses of Eli Lilly and Company, including operational finance, planning, M&A, business development and global marketing roles. Mr. Torres holds a BA from Creighton and an MBA from Michigan.
Ken Widder, M.D. , a Partner at Latterell Venture Partners, has 25 years of experience working with biomedical companies. He has founded seven companies and was Chairman/CEO of five of these, including Sytera Inc., NovaCardia, Santarus and Converge Medical. Dr. Widder started his career as a founder, Chairman and CEO of Molecular Biosystems. Dr. Widder holds an M.D. from Northwestern and trained in pathology at Duke. |
ABOUT OUR MEETINGS
The SDVG hosts eleven meetings each year, approximately one per month. Programs typically feature a panel discussion by cross-industry experts on a specific entrepreneurial or venture capital-related topic.
Please make note of the upcoming dates for San Diego Venture Group meetings, as listed on our home page (www.sdvg.org -- scroll down to "Upcoming SDVG Events"). Unless specified otherwise, the meetings are held at the Hyatt Regency in La Jolla from 7:00 - 9:00 a.m.
The non-member fee for most breakfast meeting is $45 with advance reservations ($55 at the door). SDVG members attend our standard breakfast events at no cost and receive deeply discounted rates on our "premium" events.
____________________________________________________________________
|
